Stryker stock is trading -6.87% below its average target price of $421.46 after marking a 1.6% during today's afternoon session. Analysts are giving the Large-Cap Medical Instruments & Supplies company an average rating of buy and target prices ranging from $306.0 to $465.0 per share.
The stock has a very low short interest at 1.4%, and a short ratio of 3.53. The company's insiders own 5.37% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 81.1% of Stryker's shares being owned by this investor type.
Institutions Invested in Stryker
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-03-31 | Vanguard Group Inc | 9% | 33,059,964 | $12,976,035,870 |
| 2025-03-31 | Blackrock Inc. | 7% | 27,182,853 | $10,669,269,802 |
| 2025-03-31 | Greenleaf Trust | 4% | 17,116,802 | $6,718,344,785 |
| 2025-03-31 | State Street Corporation | 4% | 14,806,528 | $5,811,562,240 |
| 2025-03-31 | JPMORGAN CHASE & CO | 3% | 12,617,277 | $4,952,281,222 |
| 2025-03-31 | Price (T.Rowe) Associates Inc | 3% | 12,131,218 | $4,761,503,065 |
| 2025-03-31 | FMR, LLC | 2% | 7,748,541 | $3,041,302,342 |
| 2025-03-31 | Geode Capital Management, LLC | 2% | 7,313,957 | $2,870,728,122 |
| 2025-03-31 | Capital Research Global Investors | 2% | 6,864,770 | $2,694,422,225 |
| 2025-03-31 | Wellington Management Group, LLP | 2% | 6,395,926 | $2,510,400,955 |
Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Stryker.
